Accedi a banche dati online | Convegnodetail
mail
Anteprima di stampa
 
 

5th Neuropsychiatric & Psychedelics Drug Development

Evvnt Promotion / evvnt
-
31.10.2022 - 02.11.2022  Crowne Plaza Boston - Woburn, an IHG Hotel, 15 Middlesex Canal Park Rd, 01801 Woburn, USA
Time: 8:15 AM - 4:00 PM
 
Temi della conferenza
With reports in depression and anxiety escalating and reaching critical levels, the urgency for developing effective, safe, and fast-acting therapeutics in psychiatry has never been greater. Advances in biomarker development, clinical endpoints, discovery platforms, and modelling have brought us to the precipice of breaking through the historical barriers in psychiatric and psychedelic drug development and into a new era of impactful treatments for this underserved community.
Professional congress organizer (PCO)
Hanson Wade
 

Informazioni ed Iscrizioni:

https://go.evvnt.com/1252699-2?pid=4832
Ms. Stephanie Nketia
 
Categorie
Medicina General
Lingua
Inglese
Quote del Congresso
USD 2599.00 - USD 4797.00
Contatto organizzatori
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Noi, Going International, siamo un’azienda che si è scelta come obiettivo di rendere acessibile la formazione a una grandissima quantità di persone, oltrepassanddo i confini geografici e sociali."

Österreichisches Rotes KreuzÄrztekammer für WienCenter of ExcellenceEuropean Public Health Association (EUPHA)Helix - Forschung & Beratung WienSwiss Tropical and Public Health InstituteOÖ Gebietskrankenkasse, Referat für Wissenschaftskooperation Alumni Club Medizinische Universität Wien